window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Merck

  • Drug discovery,Gastroenterology,Immunology,Partnerships & Funding,Research & Development

    Quotient and Merck partner on somatic genomics drug targets in inflammatory bowel disease

    Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

    March 25, 2026
  • Clinical Development,Clinical Trials,Drug approval,Oncology,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    FDA accepts Merck NDA for pimicotinib in tenosynovial giant cell tumor

    Merck has announced that the US Food and Drug Administration [...]

    January 13, 2026
  • CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Technology and platforms

    Merck opens climate-neutral €150 million filter manufacturing facility in Ireland

    Merck has inaugurated its first climate-neutral manufacturing facility in Ireland, [...]

    September 23, 2025
  • Pharmaceuticals and therapeutics,Regulatory Affairs,Research & Development

    Merck halts £1bn London research centre, raising fresh concerns over UK competitiveness

    MSD, known as Merck & Co. in the US, says [...]

    September 15, 2025
  • Biologics & Biosimilars,Drug Development,Market Access & Commercialization,Partnerships & Funding,Technology and platforms

    MSD strengthens commercial capabilities with commitment to Veeva Vault CRM ahead of major launches

    Global pharma leader MSD (Merck outside the US and Canada) [...]

    July 22, 2025
  • Clinical Development,Drug Development,Regulatory Affairs,Technology and platforms

    Certara expands clinical data collaboration with Merck to enhance digital trial efficiency

    Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

    July 9, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top